Adaptive Biotechnologies Corporation (United States) is listed on the Nasdaq and has a market capitalization of $4.48 billion, with shareholders equity totaling $183.89 million.
The company employs approximately 453 people and operates in the Health sector, within the Life Science Tools and Services industry.
Over the past 12 months, Adaptive Biotechnologies Corporation reported $298.01 million in revenue, generating net income of $-70.52 million.
Key financial metrics include a P/E ratio of -63.59, a price-to-book (P/B) ratio of 24.39, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ADPT.